Evolent Health, Inc. EVH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -296.08% | -287.10% | -355.69% | -767.39% | -77.46% |
| Total Depreciation and Amortization | 58.20% | 47.89% | 37.92% | 30.18% | -41.03% |
| Total Amortization of Deferred Charges | 7.84% | 20.30% | 13.25% | 11.35% | 1.01% |
| Total Other Non-Cash Items | 213.13% | 220.06% | 246.83% | 444.80% | 56.51% |
| Change in Net Operating Assets | 105.95% | 91.21% | 54.70% | 50.77% | -1,094.72% |
| Cash from Operations | 279.29% | 262.96% | 80.74% | 107.00% | -126.93% |
| Capital Expenditure | 68.42% | 64.40% | -114.91% | -176.38% | -238.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 22.73% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,100.00% | 106.16% | 99.81% | 99.86% | 99.85% |
| Cash from Investing | 160.59% | 153.22% | 109.74% | 99.63% | -108.58% |
| Total Debt Issued | -95.92% | -33.10% | -33.10% | 596.61% | 14.53% |
| Total Debt Repaid | 45.91% | -368.74% | -352.61% | -- | 45.18% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 92.99% | -654.47% | -612.28% | -188.04% | -178.40% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | 89.92% | 66.55% | 44.60% | 22.05% |
| Other Financing Activities | 4.50% | 75.65% | 94.79% | -66.45% | 96.73% |
| Cash from Financing | -173.06% | -180.18% | -259.89% | -6,258.23% | 184.71% |
| Foreign Exchange rate Adjustments | -270.03% | -467.84% | -553.57% | -112.23% | -257.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.20% | -191.21% | -345.91% | 104.89% | 115.68% |